Department of Rehabilitation, Kawamura Hospital, Gifu, Japan.
Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan.
NeuroRehabilitation. 2021;49(3):501-509. doi: 10.3233/NRE-210129.
There are no reports regarding the long-term retention of effects of Lee Silverman Voice Treatment® BIG (LSVT® BIG) on improvements in quality of life (QOL) among patients with Parkinson's disease (PD).
This study aimed to evaluate the short-term effect of LSVT® BIG on QOL improvement and its retention in a patient with PD. Motor symptoms, walking ability, and walking speed were evaluated as factors associated with QOL.
A 63-year-old woman who was diagnosed with PD received a 4-week LSVT® BIG program under the supervision of certified LSVT® BIG physical therapists. The participant's disease severity was classified as Hoehn and Yahr stage 2. The Parkinson's Disease Questionnaire-39 (PDQ-39), Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part 3, timed up-and-go test (TUG), and 10 m walk test (10 MWT) were evaluated before, after, and 1-year after the intervention.
The results indicated short-term improvements in the PDQ-39, MDS-UPDRS part 3, TUG, and 10 MWT which were retained for up to 1 year.
This case report suggests the possibility of 1-year retention of improvements in QOL, motor symptoms, walking ability, and walking speed resulting from LSVT® BIG intervention in a patient with mild PD.
目前尚无关于 Lee Silverman Voice Treatment® BIG（LSVT® BIG）对帕金森病（PD）患者生活质量（QOL）改善的长期效果保留的报告。
本研究旨在评估 LSVT® BIG 对 PD 患者 QOL 改善的短期效果及其保留情况。将运动症状、步行能力和步行速度评估为与 QOL 相关的因素。
一名 63 岁的女性被诊断为 PD，在经过认证的 LSVT® BIG 物理治疗师的监督下接受了为期 4 周的 LSVT® BIG 计划。患者的疾病严重程度被分类为 Hoehn 和 Yahr 2 期。在干预前、干预后和干预后 1 年评估帕金森病问卷 39 项（PDQ-39）、运动障碍协会赞助的统一帕金森病评定量表（MDS-UPDRS）第 3 部分、计时起立行走测试（TUG）和 10 米步行测试（10 MWT）。
结果表明 PDQ-39、MDS-UPDRS 第 3 部分、TUG 和 10 MWT 在短期内均有改善，且可维持长达 1 年。
本病例报告提示 LSVT® BIG 干预可能使轻度 PD 患者的 QOL、运动症状、步行能力和步行速度改善保持 1 年。
